Galapagos Stock

Galapagos FCF per Share

The Free Cash Flow per Share of Galapagos (GLPG.AS) as of Aug 17, 2026 is -3.07 EUR. In the previous year, Free Cash Flow per Share was -6.09 EUR — a change of -49.56% (higher).

FCF per Share

-3.07EUR

YoY

-49.56%

Last updated:

Free Cash Flow per Share of Galapagos is 2026 -3.07 EUR. Free Cash Flow per Share of Galapagos was 2025 -6.09 EUR. It decreases by -49.56% higher compared to the previous year.
Access this data via the Eulerpool API

Galapagos Stock analysis

What does Galapagos do? Galapagos NV is a Belgian biopharmaceutical company focused on the development of novel drugs, particularly for autoimmune diseases and fibrosis. The company was founded in 1999 by Onno van de Stolpe and is headquartered in Mechelen, Belgium. Galapagos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Galapagos stock

Free Cash Flow per Share of Galapagos is -3.07 EUR in 2026.

Free Cash Flow per Share of Galapagos changed from -6.09 EUR to -3.07 EUR, representing a -49.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Galapagos since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Galapagos

All Key Metrics — Galapagos